Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · IEX Real-Time Price · USD
8.00
-0.05 (-0.62%)
At close: Apr 19, 2024, 3:59 PM
8.13
+0.13 (1.63%)
After-hours: Apr 19, 2024, 4:12 PM EDT

Telomir Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021
Selling, General & Admin
2.370.020.01
Research & Development
1.570.830.13
Operating Expenses
3.940.850.14
Operating Income
-3.94-0.85-0.14
Interest Expense / Income
1.6400
Other Expense / Income
7.49--
Pretax Income
-13.07-0.85-0.14
Net Income
-13.07-0.85-0.14
Shares Outstanding (Basic)
2727-
Shares Outstanding (Diluted)
2927-
Shares Change
8.16%--
EPS (Basic)
-0.48-0.03-
EPS (Diluted)
-0.45-0.03-
Free Cash Flow
-3.86-0.47-0.12
Free Cash Flow Per Share
-0.14-0.02-
EBITDA
-11.43-0.85-0.14
EBIT
-11.43-0.85-0.14
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).